Establishment and verification of prediction model of occult peritoneal metastasis in advanced gastric cancer

Establishment and verification of prediction model of occult peritoneal metastasis in advanced gastric cancer

Abstract Background To investigate the risk factors associated with the development of occult peritoneal metastasis in advanced gastric cancer, and establish and externally validate a nomogram for predicting the occurrence of occult peritoneal metastasis in patients with advanced gastric cancer. Met...

Full description

Bibliographic Details
Main Authors:	Hengfei Gao, Kangkang Ji, Linsen Bao, Hao Chen, Chen Lin, Min Feng, Liang Tao, Meng Wang
Format:	Article
Language:	English
Published:	BMC 2023-10-01
Series:	World Journal of Surgical Oncology
Subjects:	Gastric cancer Claudin18.2 CA125 Occult peritoneal metastasis Nomogram
Online Access:	https://doi.org/10.1186/s12957-023-03188-2

Similar Items

Antigen-Specific T Cell Immunotherapy Targeting Claudin18.2 in Gastric Cancer
by: Bo Xu, et al.
Published: (2022-06-01)

CLDN18.2 expression and its impact on prognosis and the immune microenvironment in gastric cancer
by: Canming Wang, et al.
Published: (2023-08-01)

Anti-Claudin Treatments in Gastroesophageal Adenocarcinoma: Mainstream and Upcoming Strategies
by: Giulia Grizzi, et al.
Published: (2023-04-01)

Evidence to Date on the Therapeutic Potential of Zolbetuximab in Advanced Gastroesophageal Adenocarcinoma
by: Jane E. Rogers, et al.
Published: (2024-02-01)

Case Report: A rare case of recurrent ascites after anti-Claudin18.2 antibody therapy for metastatic gastric cancer while responding sustainingly
by: Jinlu Liu, et al.
Published: (2023-08-01)

Development of a Humanized VHH Based Recombinant Antibody Targeting Claudin 18.2 Positive Cancers
by: Weixiang Zhong, et al.
Published: (2022-06-01)

Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing
by: Daniele Lavacchi, et al.
Published: (2023-03-01)

State-of-the-Art of Monoclonal Antibodies for the Treatment of Gastric Cancer
by: Basile D, et al.
Published: (2021-11-01)

Claudin and pancreatic cancer
by: Chen Wang, et al.
Published: (2023-03-01)

Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives
by: Yasushi Sato, et al.
Published: (2023-07-01)

Tuberculous peritonitis with elevated serum CA125 levels mimicking peritoneal cancer
by: A. Taniwaki, et al.
Published: (2020-12-01)

A Prediction Model Intended for Exploratory Laparoscopy Risk Stratification in Colorectal Cancer Patients With Potential Occult Peritoneal Metastasis
by: Yuanxin Zhang, et al.
Published: (2022-07-01)

Practical nomogram based on comprehensive CT texture analysis to preoperatively predict peritoneal occult metastasis of gastric cancer patients
by: Shuxiang Chen, et al.
Published: (2022-12-01)

Efficacy and safety of zolbetuximab for first-line treatment of advanced Claudin 18. 2-positive gastric or gastro-esophageal junction adenocarcinoma: a systematic review and meta-analysis of randomized controlled trials
by: Zhanpeng Liang, et al.
Published: (2023-10-01)

Current and Emerging Role of Monoclonal Antibody-Based First-Line Treatment in Advanced Gastro-Esophageal and Gastric Cancer
by: Audrey Désilets, et al.
Published: (2023-10-01)

Claudin18.2 in Advanced Gastric Cancer
by: Rin Inamoto, et al.
Published: (2023-12-01)

Peritoneal tuberculosis: radiographic diagnosis
by: Carolina Ospina-Moreno, et al.
Published: (2014-12-01)

Claudins and Gastric Cancer: An Overview
by: Itaru Hashimoto, et al.
Published: (2022-01-01)

Dark horse target Claudin18.2 opens new battlefield for pancreatic cancer
by: Qian Xu, et al.
Published: (2024-03-01)

Development and comparison of 68Ga/18F/64Cu-labeled nanobody tracers probing Claudin18.2
by: Weijun Wei, et al.
Published: (2022-12-01)

A case report of peritoneal tuberculosis with multiple miliary peritoneal deposits mimicking advanced ovarian carcinoma
by: Shahla Yazdani, et al.
Published: (2016-01-01)

Application of Circulating Tumor Cells and Interleukin-6 in Preoperative Prediction of Peritoneal Metastasis of Advanced Gastric Cancer
by: Liu Z, et al.
Published: (2023-07-01)

Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas
by: Antonio Pellino, et al.
Published: (2021-10-01)

Relationship Between Serum CA125 Level with Malnutrition and Functional Parameters in Peritoneal Dialysis Patients
by: Nader Nori Majelan, et al.
Published: (2018-02-01)

Development and validation of nomogram of peritoneal metastasis in gastric cancer based on simplified clinicopathological features and serum tumor markers
by: Jia Yang, et al.
Published: (2023-01-01)

CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric Cancer
by: Akira Ueda, et al.
Published: (2024-02-01)

Transport Characteristics of patients on automated peritoneal dialysis may not affect their lipid profile
by: Abdullah K Al-Hwiesh, et al.
Published: (2013-01-01)

IL-15 armoring enhances the antitumor efficacy of claudin 18.2-targeting CAR-T cells in syngeneic mouse tumor models
by: Hongtai Shi, et al.
Published: (2023-07-01)

A Rare Case of Peritoneal Sarcoidosis in a 36-Year-Old Construction Worker
by: Saman Chubineh, et al.
Published: (2008-11-01)

Construction of a Human Immune Library from Gallbladder Cancer Patients for the Single-Chain Fragment Variable (<i>scFv</i>) Antibody Selection against Claudin 18.2 via Phage Display
by: Brian Effer, et al.
Published: (2024-03-01)

Primary Malignant Mesothelioma of the Peritoneum Mistaken for Peritoneal Tuberculosis due to Elevated Cancer Antigen 125
by: Ju Hyun Oh, et al.
Published: (2019-10-01)

Dawn of Targeted Therapy Using Claudin18.2 for Gastric Cancer
by: LI Hao, et al.
Published: (2023-10-01)

Nomogram to Predict Preoperative Occult Peritoneal Metastasis of Gastrointestinal Stromal Tumors (GIST) Based on Imaging and Inflammatory Indexes
by: Xu SJ, et al.
Published: (2020-11-01)

Sclerosing peritonitis associated with luteinized thecoma and elevated serum CA 125 levels: case report
by: Sabas Carlos Vieira, et al.

Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer
by: Keren Jia, et al.
Published: (2022-07-01)

Non-invasive assessment of peritoneal membrane alterations
by: Raymond Krediet, et al.
Published: (2020-08-01)

CXCL8 and the peritoneal metastasis of ovarian and gastric cancer
by: Xuanrong Fu, et al.
Published: (2023-06-01)

Development of a CLDN18.2-targeting immuno-PET probe for non-invasive imaging in gastrointestinal tumors
by: Yan Chen, et al.
Published: (2023-04-01)

Disseminated peritoneal tuberculosis simulating advanced ovarian cancer: A retrospective study of 17 cases
by: Chen-Hsuan Wu, et al.
Published: (2011-09-01)

Radiomics Nomogram for Prediction of Peritoneal Metastasis in Patients With Gastric Cancer
by: Weicai Huang, et al.
Published: (2020-08-01)